MedDeviceGuideMedDeviceGuide

MedDeviceGuide — IVD & Medical Device Knowledge Base

Regulatory

FCPA Compliance for Medical Device Manufacturers: 2025 Shifts and Case Record

A guide to US FCPA compliance for medical device manufacturers, covering the 2025 DOJ guidelines, historical cases, distributor red flags, and QMS controls.

›
Regulatory

FDA Pediatric Medical Device Regulation: Pathways, Section 515A, and Waivers

A guide to US FDA pediatric device regulation: Section 515A submissions, premarket pathways, MDUFA user-fee waivers, extrapolation, and PDC grants.

›
Reimbursement & Market Access

Medicare OPPS Device Pass-Through: CY2026 Categories and Criteria

A guide to Medicare OPPS transitional pass-through device payments, covering CY2026 categories, 42 CFR 419.66 criteria, and the FDA Breakthrough pathway.

›
Reimbursement & Market Access

DMEPOS Prior Authorization for Devices: Master, Required & the 2026 Exemption

A comprehensive guide to traditional Medicare DMEPOS prior authorization. Understand the Master and Required lists, the 2026 updates, and the 90% supplier exemption.

›
EU MDR / IVDR

EU MDR Article 97 Derogations: Legacy Device Contingency Playbook

Comprehensive guide to EU MDR Article 97 derogations, including MDCG 2022-18, Addendum 1 restrictions, national competent authority processes, and contingency planning.

›
Reimbursement & Market Access

Medicare Advantage Prior Authorization for Medical Devices: Navigating the 2026 Rules

A comprehensive guide to Medicare Advantage prior authorization for medical devices. Learn about CMS-0057-F timelines, CY2026 rules, denial rates, and appeal strategies.

›
Regulatory

Aesthetic Medical Device Adverse Events and Recalls: A MAUDE Data Analysis

A data-driven analysis of FDA MAUDE adverse events and recalls across aesthetic device classes, analyzing breast implants, lasers, dermal fillers, and cryolipolysis systems.

›
Regulatory

FDA Safer Technologies Program (STeP) for Medical Devices: Complete Regulatory Guide

A comprehensive guide to the FDA Safer Technologies Program (STeP) in 2026, including eligibility criteria, safety-innovation factors, Q-Submission application steps, benefits, and TAP pilot updates.

›
Regulatory

Medicare Coverage with Evidence Development (CED) for Medical Devices

A comprehensive guide to Medicare Coverage with Evidence Development (CED) in 2026, mapping active device NCDs, study and registry requirements, and the graduation timeline.

›
Reimbursement & Market Access

Bundled Payments for Medical Devices: BPCI-Advanced, CJR & Implant Pricing

A strategic playbook for medical device companies navigating CMS bundled payment models (BPCI-Advanced, CJR). Dissects implant pricing and NTAP/OPPS exclusions.

›
Clinical Evidence

FDA Early Feasibility Studies (EFS): The Strategic Playbook for Novel Medical Devices

A comprehensive guide to the FDA Early Feasibility Studies (EFS) Program for medical devices. Dissects EFS IDE protocols, risk mitigation, and OHT routing.

›
Reimbursement & Market Access

Outcomes-Based & Value-Based Contracts for Medical Devices: Commercial Playbook

A comprehensive guide to structuring outcomes-based and value-based contracts for medical devices. Analyzes OIG safe harbors, Stark Law, metrics, and case studies.

›
Regulatory

Certificate of Need (CON) for Medical Devices: State-by-State Guide

State-by-state guide to Certificate of Need (CON) rules for capital medical devices. Map reviewable equipment, thresholds, and sales strategy.

›
Regulatory

FDA AI-Enabled Medical Device Guidance: Transparency, Labeling & GMLP

Guide to FDA AI medical device rules. Map GMLP, June 2024 transparency, and January 2025 draft guidance to submission and labeling artifacts.

›
Regulatory

FDA Import Alerts & DWPE for Medical Devices: The Border Gate

Guide to FDA Import Alerts and Detention Without Physical Examination (DWPE) for medical devices. Learn the Red List removal and petition workflow.

›
Commercialization

Hospital Value Analysis Committees and GPOs: How US Medical Devices Get Bought

Playbook on US hospital Value Analysis Committees (VAC) and Group Purchasing Organizations (GPOs). Explains evaluation rubrics and contracting pathways.

›
Reimbursement & Market Access

HEOR and the Global Value Dossier: Building Device Evidence That Wins Reimbursement

A guide to HEOR and Global Value Dossier strategy for medical devices. Dissects device-specific economic modeling and payer evidence requirements.

›
Regulatory

Panama Medical Device Registration: The DNDM Law 90 Compliance Guide

A comprehensive regulatory guide to medical device registration and licensing in Panama under DNDM, Law 90, Executive Decree 490, and Law 419.

›
Commercialization

Aesthetic Device Market Structure: FDA 510(k) and PMA Approvals Analysis

A data-driven map of the US aesthetic medical device market, analyzing 510(k) energy devices, the laser oligopoly, PMA implants (dermal fillers and breast implants), and recalls.

›
Policy & Legislation

EU PFAS Restriction for Medical Devices: REACH Timelines and Derogations

How the EU REACH PFAS restriction affects medical device components, key transition timelines (5- and 12-year derogations), concentration limits, and substitution roadmaps.

›